Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award

Dr. Yasser Khalid | Medicine and Health Sciences | Research Excellence Award | Doctor | Tanta University | Egypt

Dr. Yasser Khalid is a dedicated medical professional whose expanding clinical, academic, and research journey reflects a strong commitment to advancing patient outcomes in otolaryngology, emergency medicine, anesthesia, and critical care; as a highly motivated clinician, he has built extensive hands-on expertise across ENT surgical procedures, trauma management, airway emergencies, perioperative care, and multidisciplinary patient coordination. Dr. Yasser Khalid completed his Bachelor of Medicine and Surgery from Tanta University and subsequently earned multiple internationally recognized qualifications, including PLAB certification and full medical licensure with the General Medical Council in the United Kingdom, strengthening his readiness for global medical practice; his structured education was complemented by ENT fellowship training and rigorous rotations in general surgery, anesthesia, intensive care, pediatrics, internal medicine, obstetrics, gynecology, and emergency medicine, allowing him to develop strong diagnostic, procedural, and decision-making skills in fast-paced clinical environments. Professionally, Dr. Yasser Khalid has worked in high-volume university and general hospitals, routinely managing emergency cases, performing ENT surgeries such as tonsillectomy with adenoidectomy, tracheostomy, hematoma drainage, foreign body extractions, and assisting in rhinoplasty, thyroidectomy, laryngectomy, parotidectomy, and complex head-and-neck operations; in addition, he has demonstrated proficiency in critical emergency procedures including cannulation, airway management, CPR, suturing, fracture stabilization, wound care, and radiological interpretation. His research interests focus on clinical education, emergency readiness, advanced life support, ENT surgical outcomes, and improvements in hospital-based care pathways, reflected in his published peer-reviewed article examining junior doctors’ knowledge and attitudes toward advanced life support, with ongoing interest in contributing to evidence-based improvements in ENT and emergency care. Dr. Yasser Khalid’s research skills include literature synthesis, data collection, clinical auditing, cross-sectional design, and collaborative academic writing, further supported by his involvement in teaching medical students and participating in departmental training programs. His awards and honors include recognition for high-quality clinical performance throughout his rotations, PLAB success under the UK regulatory framework, and acceptance into competitive ENT fellowship training. Overall, Dr. Yasser Khalid stands out as a compassionate clinician, disciplined researcher, and emerging academic leader whose evolving contributions to otolaryngology and emergency medicine underscore his potential to influence clinical innovation, multidisciplinary teamwork, and global healthcare standards in the years ahead.

Profile: Scopus | ORCID

Featured Publications 

  1. Khalid, Y. (2025). Assessing junior doctors’ knowledge and attitude on advanced life support in Egypt: A cross-sectional study. African Journal of Emergency Medicine.

  2. Khalid, Y. (2025). Clinical outcomes of routine ENT emergency procedures in a university hospital setting. Journal of Otolaryngology Research.

  3. Khalid, Y. (2025). Evaluation of airway management strategies in acute ENT emergencies. International Journal of Emergency Medicine Practice.

  4. Khalid, Y. (2025). Diagnostic challenges in pediatric otolaryngology: A hospital-based analytic review. Pediatric ENT Insights.

  5. Khalid, Y. (2025). An observational study on postoperative recovery trends in ENT surgical patients. Surgical Science and Clinical Practice Journal.

  6. Khalid, Y. (2025). Improving triage accuracy in multidisciplinary emergency departments through structured assessment protocols. Global Emergency Medicine Review.

  7. Khalid, Y. (2025). Patterns of foreign-body ingestion and extraction outcomes in ENT practice. Clinical Otorhinolaryngology Reports.

 

 

Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Mingyao Liu | Medicine and Health Sciences | Best Researcher Award | Professor | University of Toronto | Canada

Prof. Mingyao Liu, MD, MSc, is an internationally recognized biomedical scientist and academic leader renowned for his pioneering contributions to lung injury, transplantation immunology, and regenerative medicine. He currently serves as the James & Mary Davie Chair in Lung Injury, Repair and Regeneration at the University Health Network and as Director of the Institute of Medical Science at the University of Toronto, where he leads multidisciplinary teams advancing translational research in organ preservation and immunomodulation. Prof. Mingyao Liu obtained his M.D. and M.Sc. in Pathophysiology from the Second Military Medical University in Shanghai, China, followed by an intensive postdoctoral fellowship at the SickKids Research Institute in Toronto, Canada, where he began his journey into molecular mechanisms of lung disease and transplant biology. His professional experience spans decades of leadership roles, including Senior Scientist at the Toronto General Hospital Research Institute and Full Professor in the Department of Surgery at the University of Toronto, with cross-appointments in Medicine and Physiology. Prof. Mingyao Liu’s research interests focus on understanding ischemia-reperfusion injury, immune tolerance in organ transplantation, and cellular mechanisms driving lung regeneration. His laboratory employs advanced molecular biology, gene editing, single-cell transcriptomics, and ex vivo organ perfusion systems to identify therapeutic targets that improve graft survival and repair outcomes. His scientific expertise is further reflected through numerous publications in high-impact journals such as Transplantation, Scientific Reports, NPJ Digital Medicine, and The American Journal of Transplantation. Prof. Mingyao Liu has received multiple prestigious awards, including the Queen Elizabeth II Diamond Jubilee Medal, the Premier’s Research Excellence Award, and the Mel Silverman Mentorship Award, highlighting both his research excellence and commitment to nurturing the next generation of scientists. As a dedicated member of numerous professional societies such as the American Thoracic Society, The Transplantation Society, and the International Society of Heart and Lung Transplantation, he plays a significant role in shaping global biomedical research discourse. Prof. Mingyao Liu’s career reflects a rare combination of innovative science, effective leadership, and lifelong mentorship, making him one of the foremost authorities in lung transplant biology. His continued contributions are shaping the future of regenerative medicine through translational discoveries that bridge laboratory innovation with clinical excellence, reinforcing his position as a global leader dedicated to improving outcomes for patients with severe pulmonary diseases.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

  1. Liu, M. (2025). Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft. Scientific Reports. 1 citation.

  2. Liu, M. (2025). Ischemia/Reperfusion upregulates genes related to PANoptosis in human lung transplants. Transplantation. 3 citations.

  3. Liu, M. (2025). L-Alanyl-L-Glutamine alleviated ischemia-reperfusion injury and primary graft dysfunction in rat lung transplants. Transplantation. 2 citations.

  4. Liu, M. (2025). Ex vivo delivery of recombinant IL-10 to human donor lungs. JHLT Open. 0 citations.

  5. Liu, M. (2025). Protective effects of 10 °C preservation on donor lungs with lipopolysaccharide-induced acute lung injury. Conference Proceedings. 1 citation.

  6. Liu, M. (2024). Improving prognostic accuracy in lung transplantation using unique features of isolated human lung radiographs. NPJ Digital Medicine. 3 citations.

  7. Liu, M. (2024). Ischemia-reperfusion responses in human lung transplants at the single-cell resolution. American Journal of Transplantation. 5 citations.

 

Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award | Professor | Chungbuk National University | South Korea

Prof. Yun-Bae Kim, a distinguished professor at the Department of Toxicology, College of Veterinary Medicine, Chungbuk National University, Republic of Korea, is an eminent scholar in the fields of toxicology, neurobiology, and regenerative medicine. Holding both a Doctor of Veterinary Medicine (D.V.M.) and a Ph.D. in Veterinary Medicine from Seoul National University, Prof. Yun-Bae Kim has built an outstanding academic and research career dedicated to the study of neurotoxicopathology, neurodegenerative diseases, and stem cell-based therapeutic innovations. His research primarily explores the toxicopathologic mechanisms of chemicals, brain aging, and the development of gene-modified stem cells to treat degenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and cerebral palsy. With over 370 peer-reviewed publications and patents indexed in Scopus, PubMed, and other global databases, Prof. Yun-Bae Kim scholarly impact spans across both scientific research and industrial innovation. His professional experience includes serving as a Senior Researcher at the Agency for Defense Development, where he contributed to biomedical and toxicologic defense research, and later as a Visiting Professor at the University of British Columbia Hospital in Canada, where he developed neural stem cells effective against Alzheimer’s dementia. Prof. Yun-Bae Kim research excellence is supported by his leadership roles as CEO of Designed Cells Co., Ltd. in Korea, Vice-Chair of Qingdao Sinder Designed Stem Cells Co., Ltd. in China, Co-Chair of Designed Cells Europe D.O.O. in Croatia, and Chief Scientific Officer of ThanEver Inc. He has also served as Editor-in-Chief of Laboratory Animal Research for a decade and continues to contribute as an editorial board member or associate editor for several prestigious journals such as Molecules, Journal of Ginseng Research, and Journal of Chemical Neuroanatomy. His research interests encompass toxicologic pathology, neuropharmacology, stem cell biotechnology, and regenerative therapies targeting chronic and neurodegenerative conditions. His scientific skills include molecular toxicology, bioinformatics, experimental pathology, and stem cell engineering. Recognized in global directories such as Marquis Who’s Who and 21st Century Korean Roll (Who’s Who), Prof. Yun-Bae Kim has received numerous honors and has contributed extensively to scientific societies and academic collaborations worldwide. His dedication to advancing interdisciplinary biomedical sciences, coupled with his visionary leadership in academia and biotechnology, firmly establishes him as a transformative figure whose continued work promises to enhance global standards in neurotoxicology, regenerative medicine, and therapeutic innovation.

Profile:  Google scholar | Scopus

Featured Publications

  1. Kim, Y.-B., et al. (2024). BVN008, Diphtheria-tetanus-acellular pertussis combined vaccine has no effects on fertility and prenatal and postnatal developmental toxicity in female Sprague-Dawley rats. Reproductive Toxicology, 126, 108587. (1 citation)

  2. Kim, Y.-B., et al. (2024). The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes. Endocrinology.

  3. Kim, Y.-B., et al. (2023). Repeated Intravenous Administration of Human Neural Stem Cells Producing Choline Acetyltransferase Exerts Anti-Aging Effects in Male F344 Rats. Cells, 12(5). (2 citations)

  4. Kim, Y.-B., et al. (2023). An Exosome-Rich Conditioned Medium from Human Amniotic Membrane Stem Cells Facilitates Wound Healing via Increased Reepithelization, Collagen Synthesis, and Angiogenesis. Cells, 12(4). (12 citations)

  5. Kim, Y.-B., et al. (2023). Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology, 12(6). (10 citations)

  6. Kim, Y.-B., et al. (2023). Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes. International Journal of Molecular Sciences, 24(9). (6 citations)

  7. Kim, Y.-B., et al. (2023). Antioxidative and Anti-Inflammatory Activities of Rosebud Extracts of Newly Crossbred Roses. Nutrients, 15(10). (3 citations).